Literature DB >> 12911540

Mast cell infiltration and chemokine expression in progressive renal disease.

Susan E Jones1, Darren J Kelly, Alison J Cox, Yuan Zhang, Renae M Gow, Richard E Gilbert.   

Abstract

BACKGROUND: Mast cells are growth factor-rich, bone marrow-derived cells that infiltrate injured tissue where they have been implicated in the pathogenesis of progressive fibrosis.
METHODS: Mast cell infiltration and the expression of related chemoattractants was examined following 5/6 nephrectomy, a model of progressive, nonimmune-mediated renal injury. In addition, expression of the profibrotic cytokine, transforming growth factor-beta (TGF-beta) within mast cells and the effects of renoprotective therapy with angiotensin-converting enzyme (ACE) inhibition were also determined.
RESULTS: Renal injury was accompanied by mast cell infiltration, in close proximity to areas of tubulointerstitial fibrosis. Mast cells displayed toluidine blue metachromasia and were immunopositive for TGF-beta1 as well as chymase and tryptase. The expression of several mast cell chemokines, including stem cell factor, interleukin-8 (IL-8), and also TGF-beta1, were increased in 5/6 nephrectomized kidneys. ACE inhibition with ramipril led to a reduction in renal injury in association with attenuation of mast cell infiltration and chemokine expression.
CONCLUSION: Mast cell infiltration and related chemokine expression are prominent and early features following renal mass reduction and may contribute pathogenetically to progressive renal injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911540     DOI: 10.1046/j.1523-1755.2003.00183.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Comparison between the collagen intensity and mast cell density in the lingual muscles and myocardium of autopsied chronic chagasic and nonchagasic patients.

Authors:  José A Roldão; Marcela Beghini; Luciana S Ramalho; Carla Souza Porto; Denise B R Rodrigues; Vicente P A Teixeira; Sanívia A de Lima Pereira
Journal:  Parasitol Res       Date:  2012-03-13       Impact factor: 2.289

2.  Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model.

Authors:  Arul Veerappan; Alicia C Reid; Nathan O'Connor; Rosalia Mora; Jacqueline A Brazin; Racha Estephan; Takashi Kameue; Jie Chen; Diane Felsen; Surya V Seshan; Dix P Poppas; Thomas Maack; Randi B Silver
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-28

Review 3.  Mast cells and metabolic syndrome.

Authors:  Jie Zhang; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 4.  Leukocytes in glomerular injury.

Authors:  Stephen R Holdsworth; Peter G Tipping
Journal:  Semin Immunopathol       Date:  2007-10-16       Impact factor: 9.623

5.  Functional KCa3.1 K+ channels are required for human lung mast cell migration.

Authors:  G Cruse; S M Duffy; C E Brightling; P Bradding
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

6.  Mast cell infiltration and obesity-related glomerulopathy: an under-recognized disease process and new ways to approach treatment.

Authors:  Mihran Naljayan; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

Review 7.  Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.

Authors:  Itsuro Kazama
Journal:  J Physiol Sci       Date:  2014-08-06       Impact factor: 2.781

8.  Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.

Authors:  J M Zheng; G H Yao; Z Cheng; R Wang; Z H Liu
Journal:  Diabetologia       Date:  2011-12-01       Impact factor: 10.122

9.  The pathology of lithium induced nephropathy: a case report and review, with emphasis on the demonstration of mast cells.

Authors:  Kumarguru B N; Natarajan M; A H Nagarajappa
Journal:  J Clin Diagn Res       Date:  2013-02-01

10.  Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.

Authors:  Da-Hee Jeong; Gi-Ppeum Lee; Won-Il Jeong; Sun-Hee Do; Hai-Jie Yang; Dong-Wei Yuan; Ho-Yong Park; Kyu-Jong Kim; Kyu-Shik Jeong
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.